TrialBone marrow transplantation2024

Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial.

Karl-Walter Sykora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.